$2.18 Billion is the total value of Woodford Investment Management Ltd's 7 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRTA | Sell | PROTHENA CORP PLC | $735,114,000 | +19.1% | 11,349,614 | -0.4% | 33.74% | +48.9% |
| ALKS | Sell | ALKERMES PLC | $372,946,000 | -15.9% | 7,335,683 | -4.1% | 17.12% | +5.1% |
| TBPH | Sell | THERAVANCE BIOPHARMA INC | $366,577,000 | -14.1% | 10,706,108 | -0.0% | 16.83% | +7.4% |
| ABBV | Sell | ABBVIE INC | $344,364,000 | -59.9% | 3,875,358 | -67.3% | 15.81% | -49.9% |
| GILD | Sell | GILEAD SCIENCES INC | $134,946,000 | -14.1% | 1,665,592 | -25.0% | 6.19% | +7.3% |
| BIIB | Sell | BIOGEN INC | $112,750,000 | +12.7% | 360,084 | -2.3% | 5.18% | +40.9% |
| BIVV | Sell | BIOVERATIV INC | $111,876,000 | -6.0% | 1,960,325 | -0.9% | 5.14% | +17.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-06-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PROTHENA CORP PLC | 19 | Q2 2019 | 37.7% |
| ALKERMES PLC | 18 | Q1 2019 | 28.0% |
| THERAVANCE BIOPHARMA INC | 17 | Q3 2019 | 71.3% |
| BIOGEN INC | 12 | Q1 2019 | 9.8% |
| ABBVIE INC | 9 | Q3 2017 | 33.9% |
| NORTHWEST BIOTHERAPEUTICS INC | 9 | Q4 2016 | 12.7% |
| REYNOLDS AMERICAN INC | 7 | Q3 2016 | 45.9% |
| EVOFEM BIOSCIENCES INC | 7 | Q3 2019 | 20.3% |
| AUTOLUS THERAPEUTICS PLC | 6 | Q3 2019 | 33.9% |
| GILEAD SCIENCES INC | 6 | Q4 2017 | 7.6% |
View Woodford Investment Management Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Evofem Biosciences, Inc.Sold out | February 04, 2020 | 0 | 0.0% |
| Nightstar Therapeutics plcSold out | February 04, 2020 | 0 | 0.0% |
| Theravance Biopharma, Inc. | November 08, 2019 | 429,770 | 0.8% |
| Autolus Therapeutics plc | October 09, 2019 | 2,095,127 | 4.7% |
| NuCana plc | September 09, 2019 | 1,538,000 | 4.8% |
| Prothena Corp plcSold out | September 09, 2019 | 0 | 0.0% |
| NORTHWEST BIOTHERAPEUTICS INC | February 14, 2019 | 24,815,028 | 4.8% |
View Woodford Investment Management Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2020-02-04 |
| SC 13G/A | 2020-02-04 |
| 13F-HR | 2020-01-27 |
| 13F-HR/A | 2019-11-12 |
| 13F-HR | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-10-09 |
| SC 13G/A | 2019-09-09 |
| SC 13G/A | 2019-09-09 |
View Woodford Investment Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.